⌘K

Login Start Free

Home/Filings/4/0001209191-23-016629

4//SEC Filing

Friedl-Naderer Johanna 4

Accession 0001209191-23-016629

CIK 0001706431other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 2:04 PM ET

Size

4.9 KB

Accession

0001209191-23-016629

Insider Transaction Report

Form 4

Period: 2023-03-03

Vir Biotechnology, Inc.VIR

Friedl-Naderer Johanna

Chief Business Officer, Global

Transactions

Sale
Common Stock
2023-03-03$22.82/sh−1,482$33,819→ 148,518 total

Footnotes (1)

[F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Vir Biotechnology, Inc.

CIK 0001706431

Entity typeother

Related Parties

1

filerCIK 0001915598

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 2:04 PM ET
Size: 4.9 KB

View on SEC.gov